Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather H Cheng

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Urologic Oncology|March 21, 2018
The resounding effect of DNA repair deficiency in prostate cancerHeather H Cheng
The Canadian Journal of Urology|October 21, 2019
Germline contributions to metastatic prostate cancerHeather H Cheng
European Urology|May 11, 2021
Molecular Subtyping in the Neoadjuvant Setting in Prostate Cancer: Envisioning the PossibilitiesHeather H Cheng
Current Opinion in Urology|July 27, 2023
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?Celestia S Higano, Heather H Cheng
The Prostate|June 3, 2022
Germline genetics of prostate cancerHiba M Khan, Heather H Cheng
Oncology (Williston Park, N.Y.)|August 21, 2014
Targeting the androgen receptor signaling axis to reduce testosterone levels in prostate cancer: how low should we go?Heather H Cheng, Celestia S Higano
Current Oncology Reports|January 25, 2020
Genetic Testing in Prostate CancerAlexandra O Sokolova, Heather H Cheng
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 13, 2017
Hepatitis C infection and chemotherapy toxicityAmy Ly, Heather H Cheng, Laura Alwan
Virology|October 19, 2006
Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptorHeather H Cheng, Maria M Anderson, Julie Overbaugh
Journal of Hematology & Oncology|May 14, 2015
Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapyHeather H Cheng, Colleen Soleau, Evan Y Yu
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Urologic Oncology|March 21, 2018
The resounding effect of DNA repair deficiency in prostate cancerHeather H Cheng
The Canadian Journal of Urology|October 21, 2019
Germline contributions to metastatic prostate cancerHeather H Cheng
European Urology|May 11, 2021
Molecular Subtyping in the Neoadjuvant Setting in Prostate Cancer: Envisioning the PossibilitiesHeather H Cheng
Current Opinion in Urology|July 27, 2023
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?Celestia S Higano, Heather H Cheng
The Prostate|June 3, 2022
Germline genetics of prostate cancerHiba M Khan, Heather H Cheng
Oncology (Williston Park, N.Y.)|August 21, 2014
Targeting the androgen receptor signaling axis to reduce testosterone levels in prostate cancer: how low should we go?Heather H Cheng, Celestia S Higano
Current Oncology Reports|January 25, 2020
Genetic Testing in Prostate CancerAlexandra O Sokolova, Heather H Cheng
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 13, 2017
Hepatitis C infection and chemotherapy toxicityAmy Ly, Heather H Cheng, Laura Alwan
Virology|October 19, 2006
Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptorHeather H Cheng, Maria M Anderson, Julie Overbaugh
Journal of Hematology & Oncology|May 14, 2015
Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapyHeather H Cheng, Colleen Soleau, Evan Y Yu
Pageof 15